Incorporating Digital Biomarkers into ALS Trials to be Utilized as Clinically Acceptable Endpoints

Time: 1:30 pm
day: Day One Track B PM


  • Optimizing the use of digital biomarkers to help detect minor changes that ALSFRS-R scale cannot detect
  • Maximizing the deployment of real-life digital biomarker read-outs
  • Extending the application of digital measurements beyond their role as exploratory endpoints